Drug-resistance Acinetobacter baumannii infection in burn patients: Current situation and countermeasure

Chinese Journal of Burns

Volumn 27, Issue 2, 2011, Pages 84-87

  Huan, Jing Ning ^a   Tang, Jia Jun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acinetobacter baumannii; Anti bacterial agents; Burns; Drug resistance

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER INFECTION; BURN PATIENT; HOSPITAL INFECTION; NOTE; PATHOGENESIS; PREVALENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-INFECTIVE AGENTS; BURNS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS;

EID: 79955887728     PISSN: 10092587     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1009-2587.2011.02.002     Document Type: Note

References (21)

1. Keen EF 3rd, Robinson BJ, Hospenthal DR, et al. Prevalence of multidrug-resistant organisms recovered at a military burn center. Burns, 2010,36(6):819-825.
2. Choi CH, Hyun SH, Lee JY, et al. Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity. Cell Microbiol, 2008,10(2):309-319.
3. Peleg AY, Seifert H, Peterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev, 2008,21(3):538-582.
4. Seward RJ, Lambert T, Towner KJ. Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp. J Med Microbiol, 1998,47(5):455-462. (Pubitemid 28191050)
5. Bratu S, Landman D, Martin DA, et al. Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City. Antimicrob Agents Chemother, 2008,52(9):2999-3005.
6. Marchand I, Damier-Piolle L, Courvalin P, et al. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother, 2004,48(9):3298-3304. (Pubitemid 39129322)
7. Su XZ, Chen J, Mizushima T, et al. AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob Agents Chemother, 2005,49(10):4362-4364. (Pubitemid 41400988)
8. Srinivasan VB, Rajamohan G, Gebreyes WA. Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. Antimicrob Agents Chemother, 2009,53(12):5312-5316.
9. APIC. Guide to the elimination of multidrug-resistant Acinetobacter baumannii transmission in healthcare settings. Washington, D. C.: APIC, 2010.
10. King B, Schulman CI, Pepe A, et al. Timing of central venous catheter exchange and frequency of bacteremia in burn patients. J Burn Care Res, 2007,28(6):859-860. (Pubitemid 350085042)
11. Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents, 2003,21 (1):58-62. (Pubitemid 36043975)
12. Gordon NC, Wareham DW. A review of clinical and microbiological outcomes following treatment of infections involving multi-drug-resistant Acinetobacter baumannii with tigecycline. J Antimicrob Chemother, 2009,63(4):775-780.
13. Lee NY, Wang CL, Chuang YC, et al. Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study. Pharmacotherapy, 2007,27(11):1506-1511.